This website uses cookies
Read our Privacy policy and Terms of use for more information.
Oct 14, 2026
Tandem says a software issue may prevent the immediate portion of Extended Boluses from being delivered to users of the Android app.
Oct 6, 2026
Tandem Diabetes' first tubeless insulin pump is expected to reach the market in 2027, creating an entirely new category of insulin pump.
Aug 11, 2026
The insulin pump company is expanding access to pumps by tapping into new European markets and offering pay-as-you-go benefit options for U.S. customers.
Jul 1, 2026
Control-IQ+ users in the UK, Switzerland, Sweden, Finland, and Italy get a new CGM option with more countries expected to follow in 2026.
Jun 8, 2026
Backed by two major clinical trials, Tandem's t:slim X2 and Tandem Mobi are now approved in Europe for use during pregnancy and in type 2 diabetes.
May 4, 2026
The integration brings Dexcom's newest and longest-lasting CGM to the t:slim X2 automated insulin delivery system.
Apr 27, 2026
Tandem's Control IQ+ becomes the only commercially available automated insulin delivery system approved for pregnancy use in the U.S.
Apr 23, 2026
The FDA has classified the Tandem Mobi insulin pump recall as Class I after a malfunction was found to disrupt insulin delivery and CGM communication.
Mar 5, 2026
The world's smallest tubed AID system can now be controlled from Android phones, unlocking a massive untapped market.
